Allstate Corporation’s Jazz Pharmaceuticals JAZZ Stock Holding History

Allstate Corporation’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.79M	Buy	7,428 +96	+1%	+$21K	0.02%	515
2026 Q1	$1.39M	Buy	+7,332	New	+$1.28M	0.01%	677
2020 Q2	–	Sell	-2,215	Closed	-$221K	–	696
2020 Q1	$221K	Sell	2,215 -9,606	-81%	-$1.24M	0.01%	569
2019 Q4	$1.76M	Sell	11,821 -363	-3%	-$49.4K	0.03%	326
2019 Q3	$1.56M	Buy	12,184 +3,237	+36%	+$434K	0.03%	323
2019 Q2	$1.27M	Buy	+8,947	New	+$1.2M	0.02%	360
2019 Q1	–	Sell	-3,868	Closed	-$479K	–	421
2018 Q4	$479K	Buy	+3,868	New	+$574K	0.02%	330
2017 Q3	–	Sell	-12,626	Closed	-$1.96M	–	147
2017 Q2	$1.96M	Sell	12,626 -8,635	-41%	-$1.32M	0.1%	86
2017 Q1	$3.09M	Sell	21,261 -21,840	-51%	-$2.84M	0.19%	81
2016 Q4	$4.7M	Buy	+43,101	New	+$4.8M	0.28%	112

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Allstate Corporation's JAZZ Position: Q2 2026 in Review

Allstate Corporation increased its Jazz Pharmaceuticals (JAZZ) stake by 1.3% in Q2 2026, buying an estimated $21K and bringing the position to 7,428 shares worth $1.79M. The position accounts for 0.02% of the portfolio, ranked #515.

Allstate Corporation first reported a position in JAZZ in Q4 2016 and has held it in 10 quarters since. The position peaked at $4.7M in Q4 2016. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Allstate Corporation held 7,428 shares of Jazz Pharmaceuticals worth $1.79M as of Q2 2026.
Allstate Corporation bought 96 Jazz Pharmaceuticals shares in Q2 2026, an estimated $21K.
Jazz Pharmaceuticals made up 0.02% of Allstate Corporation's portfolio in Q2 2026, its #515 holding.
Allstate Corporation first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 10 quarters since.
Allstate Corporation's Jazz Pharmaceuticals position peaked at $4.7M in Q4 2016.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.